Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14

4 décembre 2017

07:00
Today, Weight Watchers International, Inc.  launches WW Freestyle, a new program that builds on the highly successful and effective SmartPoints® system by expanding zero Points foods from only fruits and vegetables to a list of more than 200...

06:48
Bayer and Loxo Oncology, Inc., , today announced updated clinical data from the larotrectinib (LOXO-101) pediatric Phase I SCOUT trial (NCT02637687). These data are being presented today at the American Association for Cancer Research (AACR) Special...

03:06
First oral short-course treatment for relapsing- remitting multiple sclerosis (RRMS) now approved in Canada, which has one of the highest rates of MS in the world[1]  Mavencladhas shown sustained clinical efficacy with a duration of oral treatment...

02:00
Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients, today announced that it has raised $30 million. The round was led by Arix Bioscience plc with participation from Adams Street Partners, Asahi...

01:53
New findings from an indirect comparison between Xultophy® and IGlarLixi published in the Journal of Medical Economics show that treatment with Xultophy® (insulin degludec/liraglutide) provides statistically significant greater reductions in blood...


2 décembre 2017

12:00
Evogen, Inc., a leader in proteomics and genomics-based testing for improved diagnosis and treatment of neurological disorders, today reported that a clinical study to be presented at the 2017 Annual Meeting of the American Epilepsy Society (AES)...

04:00
FOR MEDICAL AND TRADE MEDIA ONLY   Absolute PASI analysis from the VOYAGE 1 trial shows a high level of skin responses were maintained through two years in patients treated with guselkumab    Additional new data show a consistent safety profile...


1 décembre 2017

22:30
Xynomic Pharma, a clinical stage US oncology drug development company, today announced that it will initiate a Ph 1/2 trial, in collaboration with Janssen R&D, LLC (Janssen Pharmaceutical Companies of Johnson & Johnson, hereafter Janssen) and...

15:19
Fumoir Grizzly, en compagnie de ses partenaires l'Université Laval et Merinov, annonce qu'il a maintenant complété le développement de la bactériocine M35 et la mise au point de son procédé d'application. Appelé Bac M35, ce bio-ingrédient entièrement...

15:16
Fumoir Grizzly, with partners Université Laval and Merinov, announced that it has completed development of the M35 bacteriocin and its application process. Named Bac M35, this completely natural bioingredient protects fish from growing Listeria...

12:34
The facts about prostate cancer can be confusing. It's the third most common cancer type among Americans?161,000 men will be diagnosed this year, the National Cancer Institute estimates. Yet according to the NCI, 98.6% will be alive in 5 years....

10:01
Company supports FDA recommendation for lab, clinician and patient education about reporting all prescription medication and supplements prior to blood draws. Education on potential interferences in lab testing is important in mitigating risk...

09:00
Given the growing use and cost of multiple sclerosis (MS) medicines, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM), and Biogen, a market leader of medicines to treat MS, have partnered on an outcomes-based contract for...

09:00
sphingotec GmbH , a biotechnology company that develops biomarkers for the detection and management of diseases, has recently signed an agreement with Mayo Clinic to collaborate on the evaluation and use of several biomarkers that may improve the...

08:30
U.S. Stem Cell, Inc. , a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer Dr. Kristin Comella will present at the Healthy Masters...

08:08
Influenzavirus B Infections Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial report, "Influenzavirus B Infections Global Clinical Trials Review, H2, 2017" provides an overview of Influenzavirus B Infections clinical trials...

07:05
RXi Pharmaceuticals Corporation a clinical-stage company developing a new class of RNAi-based therapeutics and the Center for Cancer Immune Therapy (CCIT) at Herlev Hospital, a leading European center for use of tumor infiltrating lymphocytes (TIL)...

05:00
Researchers using CT scans and 3-D printing have created accurate, custom-designed prosthetic replacements for damaged parts of the middle ear, according to a study being presented today at the annual meeting of the Radiological Society of North...

02:29
InDex Pharmaceuticals Holding AB (publ) today announced new scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate. The findings show that cobitolimod can modulate the immune system in ulcerative colitis by...


30 novembre 2017

23:57
Nippon Chemiphar Co., Ltd. a annoncé que l'essai clinique de phase 1 du NC-2500, un inhibiteur de la xanthine oxydoréductase (XOR) novateur, a été terminé, indiquant qu'il a le potentiel pour réduire le risque de crise de goutte, l'un des problèmes...

22:30
Inguinal Hernia Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial report, "Inguinal Hernia Global Clinical Trials Review, H2, 2017" provides an overview of Inguinal Hernia clinical trials scenario. This report provides top...

22:29
Ileus (Intestinal Obstruction) Global Clinical Trials Review, H2, 2017Summary Read the full report: https://www.reportlinker.com/p04584178 GlobalData's clinical trial report, "Ileus (Intestinal Obstruction) Global Clinical Trials Review, H2, 2017"...

22:29
Incisional (Ventral) Hernia Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial report, "Incisional (Ventral) Hernia Global Clinical Trials Review, H2, 2017" provides an overview of Incisional (Ventral) Hernia clinical trials...

22:28
Idiopathic Short Stature Global Clinical Trials Review, H2, 2017Summary GlobalData's clinical trial report, "Idiopathic Short Stature Global Clinical Trials Review, H2, 2017" provides an overview of Idiopathic Short Stature clinical trials scenario....

22:27
Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PDRead the full report:...

22:27
Infectious Diarrhea Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial report, "Infectious Diarrhea Global Clinical Trials Review, H2, 2017" provides an overview of Infectious Diarrhea clinical trials scenario. This report...

21:58
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Global Clinical Trials Review, H2, 2017Read the full report: https://www.reportlinker.com/p03340774SummaryGlobalData's clinical trial report, "Idiopathic Thrombocytopenic Purpura...

21:53
Induced Abortion Global Clinical Trials Review, H2, 2017 SummaryGlobalData's clinical trial report, "Induced Abortion Global Clinical Trials Review, H2, 2017" provides an overview of Induced Abortion clinical trials scenario. This report provides...

21:46
Impetigo Global Clinical Trials Review, H2, 2017 SummaryGlobalData's clinical trial report, "Impetigo Global Clinical Trials Review, H2, 2017" provides an overview of Impetigo clinical trials scenario. This report provides top line data relating to...

18:20
Bayer today announced that an Independent Data Monitoring Committee (IDMC) has recommended to unblind a Phase III trial of radium Ra 223 dichloride (radium-223) in combination with abiraterone acetate and prednisone/prednisolone in prostate cancer....

17:23
TesoRx Pharma LLC, a biopharmaceutical company, today announced it commenced enrollment for a Phase 1/2a clinical trial of TSX-011 in patients with hypogonadism. TSX-011 is a novel oral testosterone replacement therapy ("TRT") to treat adult males...

16:15
Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial report, "Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2017" provides an overview of Hypertrophic Cardiomyopathy clinical trials...

14:50
A landmark real-world study of more than 18,000 patients has demonstrated superior asthma control with the AeroChamber Plus* Flow-Vu* antistatic Valved Holding Chamber (VHC, or spacer) compared with other chamber devices. 1 For those with asthma,...

13:08
Arizona State University (ASU) has joined a national initiative that brings patients, researchers, health systems and clinicians together to help people make informed healthcare decisions and improve healthcare delivery and outcomes. That innovative...

12:46
Adults with type 2 diabetes who switched their basal insulin therapy to Toujeo® or insulin degludec, experienced similar numbers of low blood sugar (hypoglycemia) events, according to the findings of two comparative real-world studies. Patients also...

11:37
The availability of Halaven® (eribulin) for the treatment of adults with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens[1] remains unaffected even though recent draft guidance from the...

11:07
Chairman Burgess, Ranking Member Greene, members of the subcommittee: Thank you for the opportunity to testify today on the anniversary of the 21st Century Cures Act, and to update you on FDA's progress in implementing the provisions of this landmark...

10:50
ReWalk Robotics' ("ReWalk" or the "Company") innovative Restore soft exoskeleton system was featured in a recent story as one of the cutting edge technologies seeking to help stroke survivors heal and retain critical motor skills.  The story...

10:18
Just ahead of another World AIDS Day, two new efficacy trials officially launched in Africa today with the potential of additional HIV prevention methods in the future. The two trials ? one studying a new vaccine...

09:00
Prelude Corporation (PreludeDx), a leader in molecular diagnostics and personalized medicine for early stage breast cancer, announced today that results from a clinical validation of DCISionRTTM?The DCIS TestTM?utilizing the SweDCIS randomized trial...

08:03
ReWalk Robotics' innovative Restore soft exoskeleton system was featured in a recent story as one of the cutting edge technologies seeking to help stroke survivors heal and retain critical motor skills.  The story published in Medical Device &...

08:00
Epic Sciences, Inc. announces the release of its breast cancer single-cell profiling panel. The Epic breast cancer panel is the most comprehensive breast cancer biomarker panel available for characterization of circulating tumor cells (CTCs) within a...

07:00
Oncolytics Biotech® Inc. (Oncolytics or the Company), a biotech company developing REOLYSIN®, also known as pelareorep, an intravenously delivered immuno-oncolytic virus that activates the innate and adaptive immune systems to turn 'cold' tumors...

05:00
Researchers have found an imbalance in the brain chemistry of young people addicted to smartphones and the internet, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). According to a...

05:00
Researchers using advanced MRI to study obese adolescents found disrupted connectivity in the complex regions of the brain involved in regulating appetite, according to a new study presented today at the annual meeting of the Radiological Society of...

02:00
Carrick Therapeutics, a biopharmaceutical company focusing on the innovative research and development of transformative oncology medicines, today announced that the first patient has been dosed in the phase 1 clinical programme of CT7001 - an orally...


29 novembre 2017

19:06
XpertDox has launched the new Clinical Trial finder search engine. This functionality will enable the patients to find all ongoing clinical trials for a particular disease. The new clinical trial finder functionality has significant improvements...

17:00
Amgen today announced that the New England Journal of Medicine (NEJM) published positive results from the six-month Phase 3 STRIVE study evaluating Aimovigtm (erenumab) versus placebo for the prevention of episodic migraine (between four and 14...

16:01
Neurocrine Biosciences, Inc. today announced that new long-term data from the open-label KINECT 4 Phase III study of INGREZZA® (valbenazine) capsules, the first FDA approved treatment for adults with tardive dyskinesia (TD), will be presented at the...

14:38
Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, announced multiple presentations at the 45th annual VEITHsymposium highlighting the safety and efficacy of the company's ENROUTE®...

1 2 3 4 5 6 7 8 9 10 11 12 13 14